Abdominal hysterectomy. Prolapse of vaginal vault after hysterectomy
Conditions
Interventions
Intervention 1: Intervention group: We inject 50 microgram Dexmedetomodine subcutaneous. Intervention 2: Intervention group: We inject 100 milligram Ketamine subcutaneous. Intervention 3: Control grou
Treatment - Drugs
Intervention group: We inject 50 microgram Dexmedetomodine subcutaneous.
Intervention group: We inject 100 milligram Ketamine subcutaneous.
Control group: We inject 5 milliliter normal saline subcutaneous.
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ?abdominal hysterectomy; general anesthesia; 30-65 years; duration of surgery maximum 120 minute; ASA I and II Exclusion criteria: allergy for Dexmedetomidine and Ketamine; duration of surgery more than 120 minute; cardiovascular and pulmonary disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean duration of analgesia?. Timepoint: 2,4 and 8 hours after surgery. Method of measurement: Minute.;Score of pain. Timepoint: 2,4 and 8 hours after surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Amount of Narcotic drug. Timepoint: End of study. Method of measurement: miligeram.;Request narcotic drug. Timepoint: First time for request narcotic. Method of measurement: Minute after surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Alireza Kamali
Arak University Of Medical Sciences
Outcome results
None listed